Crystal structure of 2,2′-oxybis(4-methylquinoline)

Crystal structure of 2,2′-oxybis(4-methylquinoline)

The title compound, C20H16N2O, (I), has been unwittingly obtained from the slow evaporation of a saturated solution of commercial benserazide hydrochloride [benserazide, (II), being one of the principal therapeutic compounds used for the management of Parkinson's disease, mostly used in combina...

Full description

Bibliographic Details
Main Author:	Anaelle Tilborg
Format:	Article
Language:	English
Published:	International Union of Crystallography 2015-02-01
Series:	Acta Crystallographica Section E: Crystallographic Communications
Subjects:	crystal structure quinoline benserazide therapeutic compounds Parkinson's disease
Online Access:	http://scripts.iucr.org/cgi-bin/paper?S2056989015000717

Similar Items

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats
by: Masoud Alirezaei
Published: (2015-10-01)

The relationship between the distinct ratios of benserazide and carbidopa to levodopa and motor complications in Parkinson's disease: A retrospective cohort study
by: Baba, Y., et al.
Published: (2022)

Crystal structure of ethyl 6-bromo-2-[(E)-2-phenylethenyl]quinoline-4-carboxylate
by: T. O. Shrungesh Kumar, et al.
Published: (2015-02-01)

Crystal structure of 2-(4-methylpiperazin-1-yl)quinoline-3-carbaldehyde
by: R Nivedita Desai, et al.
Published: (2015-11-01)

Effect of L-DOPA/Benserazide on Propagation of Pathological α-Synuclein
by: Aki Shimozawa, et al.
Published: (2019-06-01)

Metallation of 8-methylquinoline.
Published: (1993)

Crystal structures of three N-(3-acetylphenyl)quinoline-2-carboxamides
by: Diana Peña-Solórzano, et al.
Published: (2017-06-01)

Crystal structure of 4′-(2-methoxyquinolin-3-yl)-1′-methyldispiro[indan-2,2′-pyrrolidine-3′,3′′-indoline]-1,3,2′′-trione
by: Sadasivam Mathusalini, et al.
Published: (2015-12-01)

Crystal structure of N1-phenyl-N4-[(quinolin-2-yl)methylidene]benzene-1,4-diamine
by: Md. Serajul Haque Faizi, et al.
Published: (2014-09-01)

Crystal structure of diethyl 2-[(2-sulfanylquinolin-3-yl)methylidene]malonate
by: Rihanabanu, et al.
Published: (2015-08-01)

2-Oxo-1,2-dihydroquinoline-4-carboxylic acid monohydrate
by: Yassir Filali Baba, et al.
Published: (2016-06-01)

Crystal structure of ethyl 2-(3,5-difluorophenyl)quinoline-4-carboxylate
by: V. M. Sunitha, et al.
Published: (2015-05-01)

1-[6-Chloro-2-(phenanthren-9-yl)quinolin-4-yl]pyrrolidin-2-one
by: Rajamani Raja, et al.
Published: (2016-04-01)

Crystal structure of N-(2-benzoyl-5-ethynylphenyl)quinoline-2-carboxamide
by: Diana Peña-Solórzano, et al.
Published: (2017-04-01)

6-Bromo-1,2,3,4-tetrahydroquinoline-8-carbonitrile
by: Ísmail Çelik, et al.
Published: (2016-11-01)

Crystal structure of 1-tosyl-1,2,3,4-tetrahydroquinoline
by: S. Jeyaseelan, et al.
Published: (2014-11-01)

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats
by: Wen-Wen Wang, et al.
Published: (2019-06-01)

The synthesis, crystal structure and Hirshfeld analysis of 4-(3,4-dimethylanilino)-N-(3,4-dimethylphenyl)quinoline-3-carboxamide
by: Ligia R. Gomes, et al.
Published: (2020-02-01)

Crystal structure of μ-cyanido-1:2κ2N:C-dicyanido-1κC,2κC-bis(quinolin-8-amine-1κ2N,N′)-2-silver(I)-1-silver(II): rare occurrence of a mixed-valence AgI,II compound
by: Zouaoui Setifi, et al.
Published: (2015-06-01)

Crystal structure of N-(quinolin-6-yl)hydroxylamine
by: Anuruddha Rajapakse, et al.
Published: (2014-11-01)

Synthesis of 2-alkylamino-4-methylquinoline-6-r’-phenylsulfamides and their antimicrobial activity
by: I. S. Grytsenko, et al.
Published: (2013-04-01)

2H-[1,3]Thiazolo[5,4,3-ij]quinolin-3-ium chloride monohydrate
by: Madeleine A. Ehweiner, et al.
Published: (2020-11-01)

(E)-N′-Benzylidene-2-phenylquinoline-4-carbohydrazide
by: Joel T. Mague, et al.
Published: (2016-10-01)

The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists
by: Huayun Deng, et al.
Published: (2013-04-01)

Crystal structure of 3,9,9-trimethyl-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]quinolin-4-ium chloride
by: G. Sridhar, et al.
Published: (2015-07-01)

Crystal structure of N-[2-(cyclohexylsulfanyl)ethyl]quinolinic acid imide
by: Hyunjin Park, et al.
Published: (2017-09-01)

Methyl 2-phenylquinoline-4-carboxylate
by: Joel T. Mague, et al.
Published: (2016-10-01)

Crystal structure of ethyl 2-(2,4,5-trimethoxyphenyl)quinoline-4-carboxylate
by: T. O. Shrungesh Kumar, et al.
Published: (2015-07-01)

Crystal structure of 15-(naphthalen-1-yl)-7,7a,8,9,10,11-hexahydro-6a,12a-(methanoepoxymethano)indolizino[2,3-c]quinoline-6,13(5H)-dione
by: M. P. Savithri, et al.
Published: (2015-03-01)

11-[Bis(trimethylsilyl)amino]-2,4-bis(trimethylsilyl)-7,8,9,10-tetrahydro-6H-cyclohepta[1,2-b]quinoline
by: Ísmail Çelik, et al.
Published: (2017-06-01)

Crystal structure of triphenyl(quinolin-8-olato)tin(IV)
by: Mostafa M. Amini, et al.
Published: (2009-12-01)

Crystal structure, Hirshfeld surface analysis and interaction energy and DFT studies of 2-chloroethyl 2-oxo-1-(prop-2-yn-1-yl)-1,2-dihydroquinoline-4-carboxylate
by: Sonia Hayani, et al.
Published: (2019-10-01)

Ethyl 2-{[2-(2-ethoxy-2-oxoethoxy)quinolin-4-yl]carbonyloxy}acetate
by: Younos Bouzian, et al.
Published: (2018-10-01)

Hepatoprotective Effects of Betaine Against Oxidative Stress Induced by Levodopa and Benserazide in Rats
by: M Alirezaei, et al.
Published: (2015-02-01)

Di-μ-chlorido-bis(chlorido{8-[2-(dimethylamino)ethylamino]quinoline}cadmium) ethanol monosolvate
by: Abdul-Razak H. Al-Sudani, et al.
Published: (2021-02-01)

Crystal structure of ethyl 2-chloro-5,8-dimethoxyquinoline-3-carboxylate
by: Hasna Hayour, et al.
Published: (2014-09-01)

1-Ethyl-3-nitroquinolin-4(1H)-one
by: Daniel Limbach, et al.
Published: (2016-02-01)

Crystal structure, DFT study and Hirshfeld surface analysis of ethyl 6-chloro-2-ethoxyquinoline-4-carboxylate
by: Younos Bouzian, et al.
Published: (2019-06-01)

2,2′-Oxybis[1,3-bis(4-methoxyphenyl)-2,3-dihydro-1H-benzo[d][1,3,2]diazaborole]
by: Hannah H. Mallard, et al.
Published: (2020-09-01)